Literature DB >> 10090361

Limbal autografting: comparison of results in the acute and chronic phases of ocular surface burns.

S K Rao1, R Rajagopal, G Sitalakshmi, P Padmanabhan.   

Abstract

PURPOSE: To compare outcomes of limbal autograft transplantation (LAT) in the acute and chronic phases of ocular surface burns.
METHODS: Retrospective analysis of case records of 16 consecutive patients who underwent LAT for ocular surface burns, at our institute, between April 1994 and March 1997.
RESULTS: Limbal autograft transplantation was successful in reconstructing the corneal surface and restoring ocular comfort in 15 (93.8%) eyes. Limbal autografting failed to reconstruct the ocular surface in one patient undergoing surgery 2 weeks after grade IV alkali burns. In 13 eyes with counting fingers or worse vision, functional success (visual acuity >20/400) was attained after LAT in nine (69.2%) eyes. Visual acuity > or = 20/80 was achieved in two (25%) of eight eyes undergoing surgery for a persistent epithelial defect (PED) and five of six (83.3%) eyes undergoing surgery after the epithelial defect had healed (p = 0.03). Nine patients underwent simultaneous superior and inferior limbal autografting. Mean epithelial healing time in six of these patients undergoing surgery in the acute phase of injury (<4 months) was 15+/-6.1 days. In three patients undergoing a similar procedure in the chronic phase of injury, the healing time was 8.3+/-6.7 days.
CONCLUSIONS: Limbal autograft transplantation is successful in reconstructing the corneal surface and restoring ocular comfort after ocular surface burns. Surgery in the acute phase of injury (<4 months), in the presence of a PED, could result in delayed corneal reepithelialization and poorer visual prognosis. If performed in the acute phase of injury, LAT should be performed after adequate limbal vascularization and resolution of surface inflammation in the recipient eye, avoiding graft placement over ischemic limbus.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10090361     DOI: 10.1097/00003226-199903000-00004

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  15 in total

1.  Amniotic membrane transplantation for partial limbal stem cell deficiency.

Authors:  D F Anderson; P Ellies; R T Pires; S C Tseng
Journal:  Br J Ophthalmol       Date:  2001-05       Impact factor: 4.638

Review 2.  An update on chemical eye burns.

Authors:  Mukhtar Bizrah; Ammar Yusuf; Sajjad Ahmad
Journal:  Eye (Lond)       Date:  2019-05-13       Impact factor: 3.775

3.  Stem cell-based therapy for treating limbal stem cells deficiency: A review of different strategies.

Authors:  Hong He; Samuel C Yiu
Journal:  Saudi J Ophthalmol       Date:  2014-06-26

4.  Failure of amniotic membrane transplantation in the treatment of acute ocular burns.

Authors:  A Joseph; H S Dua; A J King
Journal:  Br J Ophthalmol       Date:  2001-09       Impact factor: 4.638

Review 5.  Corneal stem cells and tissue engineering: Current advances and future perspectives.

Authors:  Aline Lütz de Araujo; José Álvaro Pereira Gomes
Journal:  World J Stem Cells       Date:  2015-06-26       Impact factor: 5.326

Review 6.  Amniotic membrane transplantation for acute ocular burns.

Authors:  Gerry Clare; Catey Bunce; Stephen Tuft
Journal:  Cochrane Database Syst Rev       Date:  2022-09-01

7.  Minimal conjunctival limbal autograft for total limbal stem cell deficiency.

Authors:  Ahmad Kheirkhah; Vadrevu K Raju; Scheffer C G Tseng
Journal:  Cornea       Date:  2008-07       Impact factor: 2.651

Review 8.  Limbal stem cell transplantation: new progresses and challenges.

Authors:  L Liang; H Sheha; J Li; S C G Tseng
Journal:  Eye (Lond)       Date:  2008-12-19       Impact factor: 3.775

Review 9.  Niche regulation of limbal epithelial stem cells: HC-HA/PTX3 as surrogate matrix niche.

Authors:  Scheffer C G Tseng; Szu-Yu Chen; Olivia G Mead; Sean Tighe
Journal:  Exp Eye Res       Date:  2020-08-12       Impact factor: 3.467

10.  Coculture of autologous limbal and conjunctival epithelial cells to treat severe ocular surface disorders: long-term survival analysis.

Authors:  Sandhya V Subramaniam; Kunjal Sejpal; Anees Fatima; Subhash Gaddipati; Geeta K Vemuganti; Virender S Sangwan
Journal:  Indian J Ophthalmol       Date:  2013-05       Impact factor: 1.848

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.